Oral Nutritional Supplement Effect on HDL Function

HDL Clinical Trial

Official title:
Evaluation of an Oral Nutritional Supplement for Effect on Total High-Density Lipoprotein (HDL) Cholesterol, HDL Functionality, Particle Size and Number

Status Completed

Clinical Trial Summary

Evaluate the effects of a proprietary supplement on total HDL, HDL functionality, HDL particle size and HDL particle number (HDL-P)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04529174
Study type	Interventional
Source	Metagenics, Inc.
Contact
Status	Completed
Phase	N/A
Start date	August 18, 2020
Completion date	December 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04097119` - HDL Function Dietary Supplement Safety and QOL	N/A
Completed	`NCT01284582` - Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)	Phase 1
Completed	`NCT05641584` - Is Monocyte/HDL Ratio a Predictor of Mortality in Aortic Valve Surgery
Completed	`NCT03205254` - Effects of Short-term Diet on HDL Composition and Function	N/A
Completed	`NCT04330209` - Comparing a Low-GI Nutrigenetic and Ketogenic Diet for Weight Loss With 18 Month Follow-up
Recruiting	`NCT06190834` - Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.